ASCO 2017

02–06 June 2017 | Chicago, USA
American Society Of Clinical Oncology (ASCO) 2017 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on June 2 -6, 2016 at McCormick Place in Chicago. The conference program offers informative educational and scientific sessions on the latest cancer care treatments.

ASCO 2017

02–06 June 2017 | Chicago, USA
American Society Of Clinical Oncology (ASCO) 2017 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on June 2 -6, 2016 at McCormick Place in Chicago. The conference program offers informative educational and scientific sessions on the latest cancer care treatments.
What is the future for patients with metastatic sarcoma? 0:50
What is the future for patients with metastatic sarcoma?
Breelyn A. Wilky • 2 Jun 2017
The success of recent sarcoma studies 0:59
The success of recent sarcoma studies
Breelyn A. Wilky • 2 Jun 2017
The current landscape for sarcoma immunotherapy treatments 1:49
The current landscape for sarcoma immunotherapy treatments
Breelyn A. Wilky • 2 Jun 2017
Combining TKIs with checkpoint inhibitors for prostate cancer – is this the way forward? 1:06
Combining TKIs with checkpoint inhibitors for prostate cancer – is this the way forward?
Simon Chowdhury • 2 Jun 2017
Can vaccines and immune checkpoint inhibitors work together to treat prostate cancer? 1:35
Can vaccines and immune checkpoint inhibitors work together to treat prostate cancer?
Ravi A. Madan • 2 Jun 2017
Avelumab and axitinib for the treatment of advanced RCC 0:57
Avelumab and axitinib for the treatment of advanced RCC
Toni Choueiri • 2 Jun 2017
Pazopanib and pembrolizumab: a dangerous combination for the treatment of RCC 2:24
Pazopanib and pembrolizumab: a dangerous combination for the treatment of RCC
Simon Chowdhury • 2 Jun 2017
Is pembrolizumab alone sufficient to treat bladder cancer? 3:51
Is pembrolizumab alone sufficient to treat bladder cancer?
Thomas Powles • 2 Jun 2017
Novel therapies for the treatment of bladder cancer 1:31
Novel therapies for the treatment of bladder cancer
Thomas Powles • 2 Jun 2017
IBM Watson: Taking the world by storm and aiding in the prognosis of cancer 0:37
IBM Watson: Taking the world by storm and aiding in the prognosis of cancer
S. P. Somashekhar • 2 Jun 2017
IBM Watson in concordance with physician recommendations for cancer treatment 1:19
IBM Watson in concordance with physician recommendations for cancer treatment
S. P. Somashekhar • 2 Jun 2017
IBM Watson: a companion to physicians for treating cancer 2:56
IBM Watson: a companion to physicians for treating cancer
S. P. Somashekhar • 2 Jun 2017
Preliminary results from the study on M7824 in solid tumors 5:18
Preliminary results from the study on M7824 in solid tumors
James Gulley • 2 Jun 2017
Developing alternative treatment options for advanced melanoma 2:45
Developing alternative treatment options for advanced melanoma
Dirk Schadendorf • 2 Jun 2017
LAG-3 antibody combination in immunotherapy-treated melanoma 2:59
LAG-3 antibody combination in immunotherapy-treated melanoma
Paolo Ascierto • 2 Jun 2017
Encorafenib in a combination regimen for BRAF melanoma 3:19
Encorafenib in a combination regimen for BRAF melanoma
Paolo Ascierto • 2 Jun 2017

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals